Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine besylate plus atenolol combination therapy in mild to moderate primary hypertension
CTR20131593Phase 2Completed
- Sponsor
- China Resources Double-Crane Pharmaceutical
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amlodipine, atenolol in essential hypertension, sponsored by China Resources Double-Crane Pharmaceutical. Started Apr 2014; status: completed.
02
Drugs
amlodipineatenolol
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20131593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131593.